Literature DB >> 6153705

Cerebrospinal fluid lipids in demyelinating disease. II. Linoleic acid as an index of impaired blood-CSF barrier.

D Seidel, R Heipertz, B Weisner.   

Abstract

The absolute linoleic acid concentration in CSF was determined and the findings of MS patients (n = 10) and controls (n = 12) were compared. The linoleic acid content of control CSF (1.6 +/- 0.8 nMol/ml) is considerably lower than the corresponding serum value (2.5--4.1 muMol/ml). Although CSF from MS patients contains a significantly higher linoleic acid concentration than controls the close correlation between CSF linoleic acid and CSF albumin is maintained. The high CSF concentration of cholesterol esters rich in linoleic acid, which are abundant in serum but represent only traces in CNS lipids, points towards an impaired BBB function as the cause of CSF linoleic increase. We are able to show that both albumin and linoleic acid are suitable as "serum markers" and also as reference parameters for the overproportional IgG concentration in the CSF of MS patients. On the basis of these results it can be assumed that changes in CSF linoleic acid content are an expression of dysfunction of the blood-CSF barrier in MS and not, as had previously been postulated, the result of altered myelin metabolism.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6153705     DOI: 10.1007/BF00313116

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  11 in total

1.  [FAT METABOLISM AND CEREBROSPINAL FLUID. ON THE CONTENT OF METABOLITES OF FAT METABOLISM IN NORMAL AND PATHOLOGICAL CEREBROSPINAL FLUID].

Authors:  A SCHRADER; K SCHWARZ
Journal:  Munch Med Wochenschr       Date:  1963-12-13

2.  Cerebrospinal fluid cholesterol. Quantitative analysis of unesterified and esterified cholesterol and normal values in the cerebrospinal fluid.

Authors:  H E Pedersen
Journal:  Acta Neurol Scand       Date:  1973       Impact factor: 3.209

3.  Protein size and cerebrospinal fluid composition.

Authors:  K Felgenhauer
Journal:  Klin Wochenschr       Date:  1974-12-15

4.  Major plasma lipids and their fatty acid composition in multiple sclerosis and other neurological diseases.

Authors:  I Karlsson; C Alling; L Svennerholm
Journal:  Acta Neurol Scand       Date:  1971       Impact factor: 3.209

5.  Fatty acid profiles of cerebrospinal fluid lipids in normals and chronic alcoholics.

Authors:  J Tichy; C Alling; S J Dencker; L Svennerholm
Journal:  Scand J Clin Lab Invest       Date:  1970-03       Impact factor: 1.713

6.  Fatty acid changes of cerebrospinal fluid in neurological disorders as an index of changes in the blood-brain barrier.

Authors:  A Pazzagli; G Arnetoli; I Pepeu; L A Amaducci
Journal:  Neurology       Date:  1970-08       Impact factor: 9.910

7.  Protein fractions of lumbar, cisternal, and ventricular cerebrospinal fluid. Separate areas of reference.

Authors:  B Weisner; W Bernhardt
Journal:  J Neurol Sci       Date:  1978-07       Impact factor: 3.181

8.  [The fatty acid profile of cerebrospinal fluid lipids in demyelinating disorders].

Authors:  D Seidel; F Lindlar
Journal:  Z Neurol       Date:  1970

9.  Discrimination of elevated immunoglobulin concentrations in CSF due to inflammatory reaction of the central nervous system and blood-brain-barrier dysfunction.

Authors:  K Eickhoff; R Heipertz
Journal:  Acta Neurol Scand       Date:  1977-12       Impact factor: 3.209

10.  Cerebrospinal fluid lipids in demyelinating disease. I. Sphingolipids.

Authors:  D Seidel; R Buck; R Heipertz; H Pilz
Journal:  J Neurol       Date:  1980-01       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.